Anal HPV preva lence in a cohort of individuals infected with HIV-1

Introduction: Human Papillomavirus (HPV) is the primary etiologic agent of anogenital tract cancer. A higher prevalence and incidence of developing cancer and diseases associated with HPV have been observed in individuals infected with the human immunodeficiency virus (HIV). The natural history of...

Full description

Bibliographic Details
Main Authors: Alcina Frederica Nicol, Nathalia Silva Oliveira, David William Provance Jr, Ruth K. Friedman, Valdileia Gonçalves Veloso, Jose Ricardo Coutinho, Cynthia Braga da Cunha, Dennis de Carvalho Ferreira
Format: Article
Language:English
Published: Zeppelini Editorial e Comunicacao 2022-04-01
Series:DST
Subjects:
Online Access:https://bjstd.org/revista/article/view/743
_version_ 1811176654417952768
author Alcina Frederica Nicol
Nathalia Silva Oliveira
David William Provance Jr
Ruth K. Friedman
Valdileia Gonçalves Veloso
Jose Ricardo Coutinho
Cynthia Braga da Cunha
Dennis de Carvalho Ferreira
author_facet Alcina Frederica Nicol
Nathalia Silva Oliveira
David William Provance Jr
Ruth K. Friedman
Valdileia Gonçalves Veloso
Jose Ricardo Coutinho
Cynthia Braga da Cunha
Dennis de Carvalho Ferreira
author_sort Alcina Frederica Nicol
collection DOAJ
description Introduction: Human Papillomavirus (HPV) is the primary etiologic agent of anogenital tract cancer. A higher prevalence and incidence of developing cancer and diseases associated with HPV have been observed in individuals infected with the human immunodeficiency virus (HIV). The natural history of HPV infection has not been completely elucidated, as well as the immune response that occurs as coinfection with HIV/HPV, particularly in the anal mucosa. Objective: To analyze the HPV prevalence and clinical, epidemiological, and behavioral data in a cohort of HIV-seropositive individuals from the National Institute of Infectious Diseases, FIOCRUZ, RJ. Methods: The study included a total of 114 individuals from the histopathological diagnosis of anal biopsy. PCR and sequencing was performed for HPV DNA identification in anal discharge. Statistical analysis was performed using SPSS 15.0 software. Results: Patients Infected with HIV with anal intraepithelial neoplasia (AIN) II/III had nadir CD4 + <50 cells/mm³ compared to normal patients (p=0.01). The most prevalent HPV types in the anal secretion (by Papillocheck) were HPV 16 (29.2%), followed by HPV 52 (23.1%), both high-risk oncogenic, followed by HPV 44 and 55 (21.5%) that are low-risk type. A total of 53.3% HIV-infected individuals analyzed have already been exposed to the four HPV types targeted by the current quadrivalent vaccine (MSDm – HPV types 6, 11, 16, and 18). Conclusion: The data suggest that vaccination against HPV could be regarded as a prophylactic measure to reduce the risk of anal intraepithelial lesions in HIV-infected individuals.
first_indexed 2024-04-10T19:56:18Z
format Article
id doaj.art-a837985080464fa994c9b16fb5c292e9
institution Directory Open Access Journal
issn 2177-8264
language English
last_indexed 2024-04-10T19:56:18Z
publishDate 2022-04-01
publisher Zeppelini Editorial e Comunicacao
record_format Article
series DST
spelling doaj.art-a837985080464fa994c9b16fb5c292e92023-01-28T01:05:02ZengZeppelini Editorial e ComunicacaoDST2177-82642022-04-01281Anal HPV preva lence in a cohort of individuals infected with HIV-1Alcina Frederica NicolNathalia Silva OliveiraDavid William Provance JrRuth K. FriedmanValdileia Gonçalves VelosoJose Ricardo CoutinhoCynthia Braga da CunhaDennis de Carvalho Ferreira Introduction: Human Papillomavirus (HPV) is the primary etiologic agent of anogenital tract cancer. A higher prevalence and incidence of developing cancer and diseases associated with HPV have been observed in individuals infected with the human immunodeficiency virus (HIV). The natural history of HPV infection has not been completely elucidated, as well as the immune response that occurs as coinfection with HIV/HPV, particularly in the anal mucosa. Objective: To analyze the HPV prevalence and clinical, epidemiological, and behavioral data in a cohort of HIV-seropositive individuals from the National Institute of Infectious Diseases, FIOCRUZ, RJ. Methods: The study included a total of 114 individuals from the histopathological diagnosis of anal biopsy. PCR and sequencing was performed for HPV DNA identification in anal discharge. Statistical analysis was performed using SPSS 15.0 software. Results: Patients Infected with HIV with anal intraepithelial neoplasia (AIN) II/III had nadir CD4 + <50 cells/mm³ compared to normal patients (p=0.01). The most prevalent HPV types in the anal secretion (by Papillocheck) were HPV 16 (29.2%), followed by HPV 52 (23.1%), both high-risk oncogenic, followed by HPV 44 and 55 (21.5%) that are low-risk type. A total of 53.3% HIV-infected individuals analyzed have already been exposed to the four HPV types targeted by the current quadrivalent vaccine (MSDm – HPV types 6, 11, 16, and 18). Conclusion: The data suggest that vaccination against HPV could be regarded as a prophylactic measure to reduce the risk of anal intraepithelial lesions in HIV-infected individuals. https://bjstd.org/revista/article/view/743Papillomaviridaevaccineshomosexualitywomenanal cancer
spellingShingle Alcina Frederica Nicol
Nathalia Silva Oliveira
David William Provance Jr
Ruth K. Friedman
Valdileia Gonçalves Veloso
Jose Ricardo Coutinho
Cynthia Braga da Cunha
Dennis de Carvalho Ferreira
Anal HPV preva lence in a cohort of individuals infected with HIV-1
DST
Papillomaviridae
vaccines
homosexuality
women
anal cancer
title Anal HPV preva lence in a cohort of individuals infected with HIV-1
title_full Anal HPV preva lence in a cohort of individuals infected with HIV-1
title_fullStr Anal HPV preva lence in a cohort of individuals infected with HIV-1
title_full_unstemmed Anal HPV preva lence in a cohort of individuals infected with HIV-1
title_short Anal HPV preva lence in a cohort of individuals infected with HIV-1
title_sort anal hpv preva lence in a cohort of individuals infected with hiv 1
topic Papillomaviridae
vaccines
homosexuality
women
anal cancer
url https://bjstd.org/revista/article/view/743
work_keys_str_mv AT alcinafredericanicol analhpvprevalenceinacohortofindividualsinfectedwithhiv1
AT nathaliasilvaoliveira analhpvprevalenceinacohortofindividualsinfectedwithhiv1
AT davidwilliamprovancejr analhpvprevalenceinacohortofindividualsinfectedwithhiv1
AT ruthkfriedman analhpvprevalenceinacohortofindividualsinfectedwithhiv1
AT valdileiagoncalvesveloso analhpvprevalenceinacohortofindividualsinfectedwithhiv1
AT josericardocoutinho analhpvprevalenceinacohortofindividualsinfectedwithhiv1
AT cynthiabragadacunha analhpvprevalenceinacohortofindividualsinfectedwithhiv1
AT dennisdecarvalhoferreira analhpvprevalenceinacohortofindividualsinfectedwithhiv1